Iovance Biotherapeutics, Inc. (IOVA)
8.085
-0.36
(-4.21%)
USD |
NASDAQ |
Aug 26, 16:00
8.26
+0.18
(+2.16%)
After-Hours: 20:00
Iovance Biotherapeutics Total Return Level : 8.44 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 8.44 |
| August 24, 2026 | 8.06 |
| August 21, 2026 | 8.29 |
| August 20, 2026 | 8.99 |
| August 19, 2026 | 7.99 |
| August 18, 2026 | 7.03 |
| August 17, 2026 | 7.10 |
| August 14, 2026 | 6.98 |
| August 13, 2026 | 6.52 |
| August 12, 2026 | 6.74 |
| August 11, 2026 | 6.49 |
| August 10, 2026 | 6.40 |
| August 07, 2026 | 6.34 |
| August 06, 2026 | 6.21 |
| August 05, 2026 | 4.34 |
| August 04, 2026 | 4.36 |
| August 03, 2026 | 4.315 |
| July 31, 2026 | 4.07 |
| July 30, 2026 | 4.69 |
| July 29, 2026 | 4.56 |
| July 28, 2026 | 4.70 |
| July 27, 2026 | 4.90 |
| July 24, 2026 | 4.99 |
| July 23, 2026 | 5.13 |
| July 22, 2026 | 5.17 |
| Date | Value |
|---|---|
| July 21, 2026 | 5.48 |
| July 20, 2026 | 5.02 |
| July 17, 2026 | 5.00 |
| July 16, 2026 | 4.66 |
| July 15, 2026 | 4.74 |
| July 14, 2026 | 3.93 |
| July 13, 2026 | 4.04 |
| July 10, 2026 | 4.23 |
| July 09, 2026 | 4.37 |
| July 08, 2026 | 4.28 |
| July 07, 2026 | 4.35 |
| July 06, 2026 | 4.19 |
| July 02, 2026 | 4.31 |
| July 01, 2026 | 3.97 |
| June 30, 2026 | 4.16 |
| June 29, 2026 | 4.21 |
| June 26, 2026 | 4.25 |
| June 25, 2026 | 4.21 |
| June 24, 2026 | 4.25 |
| June 23, 2026 | 4.44 |
| June 22, 2026 | 4.06 |
| June 18, 2026 | 3.91 |
| June 17, 2026 | 3.93 |
| June 16, 2026 | 3.82 |
| June 15, 2026 | 4.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Agenus, Inc. | 8.36 |
| Amgen, Inc. | 662.22 |
| Neurocrine Biosciences, Inc. | 153.37 |
| Anika Therapeutics, Inc. | 21.40 |
| BioCryst Pharmaceuticals, Inc. | 9.83 |